From clinical to molecular diagnosis: relevance of diagnostic strategy in two cases of branchio-oto-renal syndrome - case report

Ital J Pediatr. 2022 Oct 1;48(1):177. doi: 10.1186/s13052-022-01369-5.

Abstract

Background: Branchio-oto-renal syndrome (BOR) is an autosomal dominant disorder characterized by deafness, branchiogenic malformations and renal abnormalities. Pathogenic variants in EYA1, SIX1 and SIX5 genes cause almost half of cases; copy number variants (CNV) and complex genomic rearrangements have been revealed in about 20% of patients, but they are not routinely and commonly included in the diagnostic work-up.

Case presentation: We report two unrelated patients with BOR syndrome clinical features, negative sequencing for BOR genes and the identification of a 2.65 Mb 8q13.2-13.3 microdeletion.

Conclusions: We highlight the value of CNV analyses in high level of suspicion for BOR syndrome but negative sequencing for BOR genes and we propose an innovative diagnostic flow-chart to increase current detection rate. Our report confirms a mechanism of non-allelic homologous recombination as causing this recurrent 8q13.2-13.3 microdeletion. Moreover, considering the role of PRDM14 and NCOA2 genes, both involved in regulation of fertility and deleted in our patients, we suggest the necessity of a longer follow-up to monitor fertility issues or additional clinical findings.

Keywords: Branchio-oto-renal syndrome; Copy number variation – case report; Deafness; EYA1.

Publication types

  • Case Reports

MeSH terms

  • Branchio-Oto-Renal Syndrome* / diagnosis
  • Branchio-Oto-Renal Syndrome* / genetics
  • Branchio-Oto-Renal Syndrome* / pathology
  • Homeodomain Proteins / genetics
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Nuclear Proteins / genetics
  • Pedigree
  • Protein Tyrosine Phosphatases / genetics

Substances

  • Homeodomain Proteins
  • Intracellular Signaling Peptides and Proteins
  • Nuclear Proteins
  • SIX1 protein, human
  • Protein Tyrosine Phosphatases